EUVIMEDScopri EUVIMED
Crossref

Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization

Batool Al-Lahowani, Tahrer Al-Bo Aswad, Rima Hajjo iD, Reem A Islim, Sanaa K Bardaweel iD, Kamal Sweidan, Swapnaa Balaji, Amit K Tiwari, Ghassan Abushaikha, Dima A Sabbah iD

Chemical Biology & Drug Design · 2026-06 · 107 (6)

DOI: 10.1111/cbdd.70324 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2026-05-31. Written by Batool Al-Lahowani and 9 co-authors. Institution: Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan. Major MEDLINE topics: Antineoplastic Agents, Quinolones. 99 references. Funded by: Al-Zaytoonah University of Jordan.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Cancer is a multifaceted disease that places a significant burden on healthcare systems and economies, driving the urgent need for novel therapeutic agents to curb its prevalence and impact. Thirty‐three analogues of N ‐substituted‐7‐and 8‐methyl‐4‐hydroxy‐2‐quinolone‐3‐carboxamides were synthesized and characterized using FT‐IR, NMR ( 1 H and 13 C), HRMS, and elemental analysis. The analogues displayed potential cytotoxicity against human colon cancer (HCT‐116) and epithelial colorectal adenocarcinoma (Caco‐2) cells. Compounds bearing a phenyl ring tailored with o ‐CF 3 ( 26 ) and a phenyl ring substituted with o ‐COOH and p ‐CH 3 ( 29 ) exert preferential inhibitory activity against HCT‐116 with IC 50s 9.4 and 7.8 μM. The bioinformatics calculations interpret the selectivity of analogues against HCT‐116. The principal component analysis (PCA) discloses that the analogues are regarded as lead‐like and nominated for hit‐to‐lead and lead optimization stages of drug discovery. Docking studies illustrate that analogues accommodate the kinase domain of PI3Kα and engage with key binding residues. The promising outcome of this work emphasizes the significance of this scaffold as anticancer agents.

Subjects

MeSH terms (MEDLINE)

Antineoplastic AgentsQuinolonesHumansMolecular Docking SimulationCaco-2 CellsHCT116 CellsPrincipal Component AnalysisPhosphatidylinositol 3-KinasesMethylation

Author keywords

Caco‐2HCT‐116anticancercheminformaticsinduced‐fit docking (IFD)methylated N‐benzyl‐4‐hydroxy‐2‐quinolone‐3‐carboxamides

Substances

Antineoplastic AgentsQuinolonesPhosphatidylinositol 3-Kinases

Authors and institutions

  • Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman, Jordan.
  • Department of Chemistry, The University of Jordan, Amman, Jordan.
  • Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA.
  • Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA.

ORCID profiles: Rima Hajjo, Sanaa K Bardaweel, Dima A Sabbah

Funding

  • Al-Zaytoonah University of Jordan

Cite

APA

Al-Lahowani, B., Aswad, T. A., Hajjo, R., Islim, R. A., Bardaweel, S. K., Sweidan, K., Balaji, S., Tiwari, A. K., Abushaikha, G., & Sabbah, D. A. (2026). Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization. Chemical Biology & Drug Design, 107(6). https://doi.org/10.1111/cbdd.70324

Vancouver

Al-Lahowani B, Aswad TA, Hajjo R, Islim RA, Bardaweel SK, Sweidan K, et al. Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization. Chemical Biology & Drug Design. 2026;107(6). doi:10.1111/cbdd.70324

BibTeX
@article{AlLahowani2026,
  author = {Al-Lahowani, Batool and Aswad, Tahrer Al-Bo and Hajjo, Rima and Islim, Reem A and Bardaweel, Sanaa K and Sweidan, Kamal and Balaji, Swapnaa and Tiwari, Amit K and Abushaikha, Ghassan and Sabbah, Dima A},
  title = {Investigating the Anticancer Promise of Synthesized Methylated N ‐Substituted‐4‐Hydroxy‐2‐Quinolone‐3‐Carboxamides: Biological and Computational Characterization},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {6},
  doi = {10.1111/cbdd.70324}
}
Start for free →